Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Massachusetts General Hospital
The objective of this study is to evaluate the efficacy and safety of ustekinumab, an interleukin (IL)-12/23 inhibitor, in patients with GCA Hypothesis IL-12/23 pathway blockade may maintain disease remission in patients with GCA Specific Aims * To evaluate the safety and tolerability of ustekinumab administration in 20 patients with GCA * To evaluate the efficacy of ustekinumab for remission maintenance and glucocorticoid sparing in 20 patients with GCA
Age
50–any
Sex
ALL
Healthy volunteers
Not accepted